Histamine glutarimide

DB16016InvestigationalSmall molecule

Histamine glutarimide is under investigation in clinical trial NCT03450434 (XC8 in the Treatment of Patients With Bronchial Asthma).

Chemical structure of Histamine glutarimide
Formula / weight
C10H13N3O2 · 207.233 g/mol (avg)
Code names
XC-8

Resolves to

Compound
UNIIVOM9DP10M3CAS1464897-15-1
Structure
InChIKeyDYKZYSKWOHKZMF-UHFFFAOYSA-NSMILESO=C1CCCC(=O)N1CCC1=CN=CN1

What you can answer from here — as of December 12, 2020

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Histamine glutarimide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In